EUCRATES BIOMEDICAL ACQUISITION CORP.EUCRW 0.18
EPS (as of 2022-12-31)
Use left/right arrow keys to switch.Breakdowns
Name | Value |
---|
Revenues | 0.0K |
Cost of Revenue | 0.0K |
Gross Profit | 0.0K |
Operating Expense | 166.9K |
Operating I/L | -166.9K |
Other Income/Expense | 688.2K |
Interest Income | 222.4K |
Pretax | 521.3K |
Income Tax Expense | -688.2K |
Net Income/Loss | 1,209.5K |
Eucrates Biomedical Acquisition Corp.
Trending Profiles
This is the ALPHA version. The tool and data may contain incorrect information. Please read it with caution.